Babbitt leads cancer drug study

Gregory Babbitt, associate professor in the Thomas H. Gosnell School of Life Sciences, is the lead author of a computational cancer drug study, with collaborators at HWI-Buffalo and Georgetown University Medical Center. Based on machine learning software/method published earlier in the year and presented at the 2020 Biophysical Society Meeting, the work was part of a long-term intellectual collaboration with Ernest Fokoue, professor in RIT’s School of Mathematical Sciences.

Recommended News